Anissa A. Widjaja

3.8k total citations
29 papers, 752 citations indexed

About

Anissa A. Widjaja is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Anissa A. Widjaja has authored 29 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Anissa A. Widjaja's work include Cytokine Signaling Pathways and Interactions (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Anissa A. Widjaja is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Anissa A. Widjaja collaborates with scholars based in Singapore, United Kingdom and Germany. Anissa A. Widjaja's co-authors include Stuart A. Cook, Sivakumar Viswanathan, Sonia Chothani, Sebastian Schäfer, Wei‐Wen Lim, Benjamin Ng, Shamini G. Shekeran, Jessie Tan, Jinrui Dong and Eleonora Adami and has published in prestigious journals such as Nature Communications, PLoS ONE and Circulation Research.

In The Last Decade

Anissa A. Widjaja

28 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anissa A. Widjaja Singapore 16 229 208 176 175 147 29 752
Martin Mollenhauer Germany 17 321 1.4× 294 1.4× 163 0.9× 114 0.7× 80 0.5× 43 997
Adi Mor Israel 15 193 0.8× 604 2.9× 181 1.0× 192 1.1× 74 0.5× 32 1.1k
Cristian Perna Spain 15 246 1.1× 208 1.0× 242 1.4× 314 1.8× 71 0.5× 47 1.0k
Václav Eis Czechia 14 138 0.6× 314 1.5× 178 1.0× 63 0.4× 100 0.7× 21 830
Toshiyuki Bohgaki Japan 21 449 2.0× 260 1.3× 177 1.0× 182 1.0× 164 1.1× 65 1.2k
Geneviève Soucy Canada 17 118 0.5× 291 1.4× 153 0.9× 194 1.1× 79 0.5× 37 811
Chong Lu China 22 571 2.5× 226 1.1× 268 1.5× 146 0.8× 255 1.7× 56 1.2k
Shiva Kumar Shanmukhappa United States 15 139 0.6× 129 0.6× 139 0.8× 190 1.1× 106 0.7× 22 724
Mikio Kajihara Japan 19 275 1.2× 233 1.1× 263 1.5× 186 1.1× 72 0.5× 49 908
Benjamin Stoelcker Germany 18 403 1.8× 294 1.4× 130 0.7× 95 0.5× 83 0.6× 25 904

Countries citing papers authored by Anissa A. Widjaja

Since Specialization
Citations

This map shows the geographic impact of Anissa A. Widjaja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anissa A. Widjaja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anissa A. Widjaja more than expected).

Fields of papers citing papers by Anissa A. Widjaja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anissa A. Widjaja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anissa A. Widjaja. The network helps show where Anissa A. Widjaja may publish in the future.

Co-authorship network of co-authors of Anissa A. Widjaja

This figure shows the co-authorship network connecting the top 25 collaborators of Anissa A. Widjaja. A scholar is included among the top collaborators of Anissa A. Widjaja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anissa A. Widjaja. Anissa A. Widjaja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeney, Mark, Michael S. Lee, Henrike Maatz, et al.. (2024). Interleukin 11 therapy causes acute left ventricular dysfunction. Cardiovascular Research. 120(17). 2220–2235. 1 indexed citations
2.
Ng, Benjamin, Kevin Huang, Chee Jian Pua, et al.. (2024). Interleukin-11 causes alveolar type 2 cell dysfunction and prevents alveolar regeneration. Nature Communications. 15(1). 8530–8530. 5 indexed citations
3.
Widjaja, Anissa A. & Stuart A. Cook. (2024). Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130. International Journal of Molecular Sciences. 25(3). 1363–1363. 3 indexed citations
4.
Sweeney, Mark, Michael Lee, Konstantinos Vanezis, et al.. (2023). Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction. International Journal of Molecular Sciences. 24(16). 12989–12989. 15 indexed citations
5.
Lim, Wei‐Wen, Jinrui Dong, Benjamin Ng, et al.. (2022). Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome. Circulation Research. 130(5). 728–740. 32 indexed citations
6.
Ng, Benjamin, Sivakumar Viswanathan, Anissa A. Widjaja, et al.. (2022). IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis. International Journal of Molecular Sciences. 23(7). 3549–3549. 19 indexed citations
7.
Dong, Jinrui, Wei‐Wen Lim, Shamini G. Shekeran, et al.. (2022). Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury. International Journal of Molecular Sciences. 23(13). 7089–7089. 5 indexed citations
8.
Zhou, Jin, Madhulika Tripathi, Jia Pei Ho, et al.. (2022). Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression. Nature Communications. 13(1). 5202–5202. 55 indexed citations
9.
Widjaja, Anissa A., Sivakumar Viswanathan, Shamini G. Shekeran, et al.. (2022). Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease. Nature Communications. 13(1). 7497–7497. 41 indexed citations
10.
Widjaja, Anissa A., Sonia Chothani, Sivakumar Viswanathan, et al.. (2022). IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues. International Journal of Molecular Sciences. 23(16). 8900–8900. 40 indexed citations
11.
Widjaja, Anissa A., Sivakumar Viswanathan, Joyce Wei Ting Goh, et al.. (2022). IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells. iScience. 25(8). 104806–104806. 23 indexed citations
12.
Lim, Wei‐Wen, Ben Corden, Lei Ye, et al.. (2021). Antibody‐mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload. Clinical and Experimental Pharmacology and Physiology. 48(4). 605–613. 11 indexed citations
13.
Dong, Jinrui, Sivakumar Viswanathan, Eleonora Adami, et al.. (2021). The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling. eLife. 10. 10 indexed citations
14.
Adami, Eleonora, Sivakumar Viswanathan, Anissa A. Widjaja, et al.. (2021). IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts. Lara D. Veeken. 60(12). 5820–5826. 42 indexed citations
15.
Dong, Jinrui, Sivakumar Viswanathan, Eleonora Adami, et al.. (2021). Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH. Nature Communications. 12(1). 66–66. 89 indexed citations
16.
Ng, Benjamin, Anissa A. Widjaja, Sivakumar Viswanathan, et al.. (2021). Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis. Scientific Reports. 11(1). 14088–14088. 37 indexed citations
17.
Widjaja, Anissa A., Sonia Chothani, & Stuart A. Cook. (2020). Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy. Human Vaccines & Immunotherapeutics. 16(10). 2357–2362. 33 indexed citations
18.
Lim, Wei‐Wen, Benjamin Ng, Anissa A. Widjaja, et al.. (2020). Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice. PLoS ONE. 15(1). e0227505–e0227505. 53 indexed citations
19.
Lim, Wei‐Wen, Ben Corden, Benjamin Ng, et al.. (2020). Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models. Scientific Reports. 10(1). 17853–17853. 48 indexed citations
20.
Thorns, Christoph, et al.. (2009). Maternally-inherited diabetes and deafness: Report of two affected German families with the A3243G mitochondrial DNA mutation. Experimental and Clinical Endocrinology & Diabetes. 106(5). 384–388. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Mollenhauer Breakdown of academic impact, for papers by Adi Mor Breakdown of academic impact, for papers by Cristian Perna Breakdown of academic impact, for papers by Václav Eis Breakdown of academic impact, for papers by Toshiyuki Bohgaki Breakdown of academic impact, for papers by Geneviève Soucy Breakdown of academic impact, for papers by Chong Lu Breakdown of academic impact, for papers by Shiva Kumar Shanmukhappa Breakdown of academic impact, for papers by Mikio Kajihara Breakdown of academic impact, for papers by Benjamin Stoelcker
Rankless by CCL
2026